Senior Fellows
COCE’s Senior Fellows advise and assist the Expert Leaders in carrying out
their functions. The Senior Fellows are composed of the Nation’s leading experts
in the field of co-occurring disorders.
Barry Brown, Ph.D.
Dr. Brown holds an appointment with the University of North Carolina at Wilmington and is currently engaged in study in the areas of treatment engagement, aftercare, and the application of treatment research to clinical practice. He has been involved with drug abuse treatment and research for more than 35 years, working in both community-based and correctional treatment programs, as well as working in a variety of roles involving the administration of treatment and community research during a 17-year career with the National Institute on Drug Abuse.
Carlo DiClemente, M.A., Ph.D.
Dr. DiClemente is a professor of psychology at the University of Maryland, Baltimore County, and the internationally recognized co-creator (with James Prochaska, Ph.D.) of the Transtheoretical Model of Change. He is the author of numerous scientific articles and book chapters on motivation and behavior change and the application of this model to a variety of problem behaviors. He has directed an outpatient alcoholism treatment program and served as a consultant to private and public treatment programs. For the past 20 years, Dr. DiClemente has conducted funded research in health and addictive behaviors and is a member of the Project MATCH and Project COMBINE clinical trial research groups.
His current research interests include smoking initiation and cessation, alcoholism and substance abuse treatment, dual diagnosis, early intervention with problem drinkers, pregnancy smoking cessation, and initiation of health protection and health threatening behaviors. Dr. DiClemente was given the 2002 Award for Outstanding Scientific Contribution to Psychology by the Maryland Psychological Association and has received the Distinguished Scientific Contribution Award from the American Psychological Association’s Division on Addiction. DiClemente was one of five individuals selected to receive The Robert Wood Johnson Foundation’s Innovators Combating Substance Abuse award in 2002.
Robert E. Drake, M.D., Ph.D.
Dr. Drake is the Andrew Thomson Professor of Psychiatry and Community and Family Medicine at Dartmouth Medical School and the Director of the New Hampshire-Dartmouth Psychiatric Research Center. He has been at Dartmouth for 20 years. In addition to working actively as a clinician in community mental health centers for 25 years, he has been developing and evaluating innovative community programs for persons with severe mental disorders. He is well known for his work in rehabilitation and health services research. His 8 books and 300 papers cover diverse aspects of adjustment and quality of life among persons with severe mental disorders and those in their support systems.
Michael W. Kirby, Jr., Ph.D.
Michael W. Kirby, Jr., Ph.D. has been Chief Executive Officer for Arapahoe House, Inc., in Thornton, Colorado since 1983. With an annual budget of approximately $28 million, Arapahoe House is Colorado’s largest provider of substance abuse treatment services and is also a licensed mental health clinic. Dr. Kirby served as President of the Rocky Mountain Institute for Alcohol and Drug Education, a non-profit education and advocacy organization. He serves on the Board of Directors for Signal Behavioral Health Network, and is the immediate past president of this board.
He is also the Chief Executive Officer and Board Chair of Flatirons Behavioral Health Corporation, which owns and manages Centennial Peaks Hospital, a 72-bed psychiatric hospital. Dr. Kirby is on the Board of Directors of the Mental Health Association of Colorado and currently serves as a Vice-President for this board. Dr. Kirby has authored numerous publications and presentations on substance abuse and behavioral health care.
David Mee-Lee, M.D.
Dr. Mee-Lee is a board-certified psychiatrist and is certified by examination of the American Society of Addiction Medicine (ASAM). Based in Davis, California, Dr. Mee-Lee is involved in training and consultation full-time and also consults to national managed behavioral healthcare companies. He has focused for over 25 years on developing and promoting innovative behavioral health treatment that values clinical integrity, high quality, and cost-consciousness.
In addition, he has more than 25 years’ experience with co-occurring substance-related and mental health treatment and program development. Dr. Mee-Lee has authored a number of book chapters and papers in a variety of professional publications. He is Chair of the Coalition for National Clinical Criteria. He co-authored the first and second editions of the ASAM Criteria; and is the Chief Editor of the Revised Second Edition of the ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, ASAM PPC-2R, published in April 2001.
Dr. Mee-Lee also publishes an electronic newsletter, "TIPS and TOPICS" Sign up for FREE "TIPS & TOPICS" at http://www.dmlmd.com/index.html
Kenneth Minkoff, M.D.
Dr. Minkoff is a clinical assistant professor of psychiatry at Harvard Medical School. He is recognized as one of the Nation's leading experts on integrated treatment of individuals with co-occurring psychiatric and substance disorders or "dual diagnosis," and on the development of integrated systems of care for such individuals, through the implementation of a national consensus best practice model for systems design: the Comprehensive Continuous Integrated System of Care (CCISC). He has developed an integrated conceptual framework for treatment of co-occurring disorders based on application of a disease and recovery model for each disorder. He has lectured widely on this topic since 1985. In 1991, Dr. Minkoff co-edited Dual Diagnosis of Serious Mental Illness and Substance Disorder. Dr. Minkoff participated in a national task force to create the American Society of Addiction Medicine’s Patient Placement Criteria 2R (1999).
In 1996, Dr. Minkoff was appointed to chair the Center for Mental Health Services Managed Care Initiative expert consensus panel on co-occurring disorders, and was lead author of the panel report titled: Co-occurring Psychiatric and Substance Disorders in Managed Care Systems: Standards of Care, Practice Guidelines, Workforce Competencies and Training Curricula (1998). Dr. Minkoff also co-authored an issues paper on co-occurring disorders for the President’s New Freedom Commission (2002). He is currently consulting to, or has consulted to, a number of States that are involved in the adaptation of this model for implementation in their own systems, including Alabama Arizona, Louisiana, Pennsylvania, and Massachusetts.
Dr. Minkoff’s major professional activity is the provision of training and consultation on clinical services and systems design for individuals with co-occurring disorders; he is engaged in numerous ongoing projects for implementing CCISC at State and regional levels in both the United States and Canada. With his consulting partner, Christie A. Cline, M.D., M.B.A. (Medical Director for the Behavioral Health Services Division of the New Mexico Department of Health), Dr. Minkoff has developed a systems change toolkit for CCISC implementation.
More information on Dr. Minkoff and Dr. Cline and their services and products can be obtained through their co-occurring Web site at www.kenminkoff.com
Bert Pepper, M.D.
Dr. Pepper is a clinical professor of Psychiatry at NYU School of Medicine, a Lecturer of Psychiatry at Harvard Medical School, and a member of the Faculty of Massachusetts Mental Health Center. He is the former founder and executive director of The Information Exchange, Inc., and the former commissioner of the Rockland County Community Mental Health Center, Rockland County, NY. He is a past president of the American Orthopsychiatric Association and the former director of Consultation Service of the American Psychiatric Association. In addition, Dr. Pepper is a Former Commissioner of the State of Maryland’s Department of Mental Hygiene, a member of the National Advisory Council of the Substance Abuse and Mental Health Service Administration, and a member of the Substance Abuse Task Force for the National Mental Health Association.
Stephanie W. Perry, M.D.
Stephanie W. Perry serves as the Assistant Commissioner of Health for the Tennessee Bureau of Alcohol and Drug Abuse Services, which provides effective prevention intervention and treatment of alcohol, tobacco, and other drug abuse, service to individuals, families, and local communities within the State. Dr. Perry was the first Director of the Office of Minority Health for the State of Tennessee.
Dr. Perry co-founded and worked as a pediatrician, director of special programs, and chief financial officer for the Family Wellness Center. She performed community outreach services and screening to daycare centers and developed various pediatric consulting and medical evaluation programs. Dr. Perry was a Field Review participant for the American Society of Addiction Medicine Patient Placement Criteria, Second Edition. She is a member of the Rehabilitation Accreditation Commission field review committee, and a member of the National Diabetes Education Program Committee for special populations and for children with diabetes.
She serves on the SAMHSA Center for Mental Health Services National Advisory Council and is a Board Member of the Community Anti-Drug Coalitions of America. She is also a member of the TennCare Partners (managed care) Roundtable and the Statewide Mental Health and Developmental Disabilities Planning and Policy Council.
Rick Ries, M.D.
Dr. Ries is Professor of Psychiatry at the University of Washington Medical School in Seattle. He is board certified in General Psychiatry and in Addiction Psychiatry by the American Board of Psychiatry and Neurology and certified in Addiction Medicine by the American Society for Addiction Medicine. Dr. Ries is Director of Outpatient Psychiatry, Dual Disorder Programs, and the Addictions Programs at Harborview Medical Center in downtown Seattle. He is Director of substance abuse education for the University of Washington Medical School and Director of the Division of Addictions for the Department of Psychiatry. He has obtained NIDA-sponsored clinical research grants in 1989 and 1997 to evaluate treatment outcome in dual disorders, and has been co-investigator on a number of other grant projects, including the NIDA Clinical Trials Network.
He chaired the first national Treatment Improvement Protocol on assessment and treatment of persons with co-occurring addiction and mental disorders, and is currently co-chair of its update. In 1999 he became a co-editor of the key reference text, Principles of Addiction Medicine, published by the American Society of Addiction Medicine, and is now its senior editor. Dr. Ries has developed and directed large inpatient psychiatric and dual disorder services at both University and Harborview Medical Centers. Most of his research has dealt with studying the clinical populations involved in the various services he has developed and run, especially those focused on difficult-to-treat, often dually diagnosed populations.
Dr. Ries has received the Nancy Roeske teaching award from the American Psychiatric Association for his work with medical students, is a former president of the Washington State Association of Community Psychiatrists, and has been selected as one of the "Best Doctors in America" each year since 1995.
Linda Rosenberg, M.S.W., CSW
Ms. Rosenberg is the new President and CEO of the National Council for Behavioral Healthcare. Previously, Ms. Rosenberg served as Senior Deputy Commissioner for the New York State Office of Mental Health. In this position, she led the design and implementation of community-based services for adults and children and provided operational support and oversight for New York’s mental health treatment and rehabilitation system.
Ms. Rosenberg is a certified social worker, as well as a trained family therapist and psychiatric rehabilitation practitioner. She has extensive experience in the design, implementation, and management of hospital and community programs. She has taught and served as a field instructor for many of the New York City graduate schools of social work and holds a faculty appointment as a public service professor at the School of Social Welfare at Albany, State University of New York.
Richard N. Rosenthal, M.D.
Dr. Rosenthal is a Professor of Clinical Psychiatry at Columbia University and Chairman of Psychiatry at St. Luke's-Roosevelt Hospital Center, NY. He is also the Immediate Past President of the American Academy of Addiction Psychiatry, a Distinguished Fellow of the American Psychiatric Association, and a Fellow of the New York Academy of Medicine. He is a diplomate of the American Board of Psychiatry and Neurology in psychiatry, with subspecialty certification in addiction psychiatry. Prior to joining St. Luke's-Roosevelt, he was associate chairman for clinical services of the Beth Israel Medical Center, NY (BIMC) department of psychiatry and director of the division of substance abuse at Albert Einstein College of Medicine.
Previously, he served first as Unit Chief and then Division Chief of the Substance Abuse Service (Psychiatry) at BIMC. During this time, he created the Combined Psychiatric and Addictive Disorders treatment research program, and co-developed and manualized Brief Supportive Psychotherapy for Beth Israel's Brief Psychotherapy Research Program. Dr. Rosenthal's main research focus has been on the evaluation and treatment of the severely mentally ill with co-occurring addictive disorders, and he has been a clinical, research, and program development consultant to hospitals and State and Federal agencies. He also has a long-term interest in medical informatics and is on the steering committee of the American Association for Technology in Psychiatry, as well as the Information Systems Review Committee of the New York State Hospital Planning and Review Council.
In 2004, Governor Pataki appointed Dr. Rosenthal to the NY State Mental Health Services Council. Dr. Rosenthal has received numerous awards and honors including New York Magazine's Best Doctors in New York in 1998 – 2004. He has authored 50 peer-reviewed journal articles, book chapters, and books. He maintains a private practice of psychotherapy and psychopharmacology for mood and addictive disorders.
Douglas M Ziedonis, MD, MPH
Dr. Ziedonis is a Professor of Psychiatry and Director of Addiction Psychiatry at the University of Medicine and Dentistry of New Jersey's (UMDNJ) Robert Wood Johnson Medical School. He is also a Professor in Health Systems and Policy at the UMDNJ School of Public Health and Visiting Professor at Rutgers University Center for Alcohol Studies and Princeton Seminary. Dr. Ziedonis has dedicated his career to better understanding and treating co-occurring mental illness and addiction, including addressing tobacco dependence in mental health and addiction settings. He is the recipient of numerous awards and grants from the National Institute of Mental Health, National Institute of Drug Abuse, Center for Substance Abuse Treatment, Robert Wood Johnson Foundation and other agencies, including a NIDA Career Development Award.
He has written over 100 book chapters and peer-reviewed publications and has co-edited three books, including the Integrated Treatment for Mood and Substance Use Disorders and the Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. He serves as a co-occurring disorder advisor to many agencies, states, and federal groups including President Bush's New Freedom Commission on Mental Health, the National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Agency, including on the Report to Congress on the Prevention and Treatment of Co-Occurring Substance Abuse Disorders and Mental Disorders. He also works as a clinician and program director in developing better co-occurring disorder services. Dr. Ziedonis led a national initiative for The Robert Wood Johnson Foundation to develop a national agenda on how to Address Tobacco in Mental Health and Addiction Settings.
Joan Ellen Zweben, Ph.D.
Dr. Zweben is the founder and Executive Director of The East Bay Community Recovery Project and The 14th Street Clinic & Medical Group in Sacramento, California, and has steadily developed the medical and psychosocial services of these affiliated organizations. Her activities as an author, teacher, and consultant keep her informed of new developments in the field. She is the author of 2 books, over 55 articles or book chapters, and editor of 15 monographs on treating addiction.
Dr. Zweben is a clinical psychologist with over 35 years' experience in
treating addiction and training treatment practitioners. These practitioners
include peer counselors, social workers, marriage and family counselors,
psychologists, probation officers, nurses, and physicians. She has a
broad-based background in both alcoholism and drug dependence, experience with
both residential and outpatient modalities, and has consistently emphasized the
importance of co-occurring disorders in her work. She has a long-standing
commitment to building treatment resources through networking activities.
